Hypertensive Disorder of Pregnancy Clinical Trial
Official title:
Risk Analysis of Intensive Care Management on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
Laboratory monitoring of patients included serial measurement of complete blood cell count,
liver function tests, coagulation profile, and renal function tests.
ICU management during conduction of the research study included the following:
Control of convulsions using magensium sulphate. Control of blood pressure Diastolic blood
pressure above 110 mmHg, nifedipine was administered.A plasma volume expansion with saline
was used in all women to maintain sufficient intravascular volume. Delivery was performed
immediately after hemodynamic stabilization and clinical control of general condition .
Laboratory monitoring of patients included serial measurement of complete blood cell count,
liver function tests, coagulation profile, and renal function tests.
ICU management included the following:
Control of convulsions by Loading dose of magensium sulphate (4-6g I.V), given over 20
minutes in 100 ml of dextrose then Maintenance dose (4-6g) magensium sulphate in 500 cc
dextrose given over 8 hours using continuous IV drip.Control of blood pressure if Diastolic
blood pressure above 110 mmHg, nifedipine was administered. Delivery was performed
immediately after hemodynamic stabilization and clinical control of general condition
.Termination of gestation decision was based on the the presence of maternal complications,
fetal distress.After delivery the patient is retrurned to ICU under clinical and careful
observation of the following:Heart rate, blood pressure,every 15 min,Temperature and
respiratory rate ,evey 4 hours. Duration of admission in the ICU was assessed
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
| Recruiting |
NCT05687344 -
Intensive Postpartum Antihypertensive Treatment
|
Phase 3 | |
| Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
| Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
| Recruiting |
NCT05995106 -
mHealth for Hypertensive Disorder of Pregnancy
|
N/A | |
| Completed |
NCT03309826 -
Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy
|
N/A | |
| Completed |
NCT05631067 -
Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality
|
N/A | |
| Completed |
NCT03728790 -
Remote BP Monitoring in the PP Period
|
N/A | |
| Recruiting |
NCT05089175 -
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
|
||
| Enrolling by invitation |
NCT05763069 -
HOME: Home Monitoring of High-risk Pregnancies
|
||
| Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
| Recruiting |
NCT05659173 -
Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension
|
||
| Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
| Completed |
NCT05124327 -
Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy
|
N/A | |
| Recruiting |
NCT06362356 -
Microbial Metabolites and Outcomes of Pregnancy Study
|
||
| Active, not recruiting |
NCT04580927 -
Breastfeeding and Postpartum Cardiovascular Health
|
N/A | |
| Recruiting |
NCT05655936 -
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
|
N/A | |
| Enrolling by invitation |
NCT05835596 -
MumCare: Mum's Cardiovascular Health for Life
|
N/A | |
| Completed |
NCT06019715 -
Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy
|
N/A | |
| Not yet recruiting |
NCT06220721 -
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
|
Phase 3 |